A summary of the average weighted annual cost for each drug is shown at the top of the unit cost tab in the resource imapct template. When deciding between vadadustat and ESAs, and after the ...

Then just last month it rejected Akebia's vadadustat on the grounds that the ... kept in refrigerated storage unlike injectables. GSK's drug – which is also under regulatory review in Europe ...

The US regulator said that the drug's efficacy was not in question ... Akebia has filed for FDA approval of vadadustat with a decision due by 29 March next year, while GSK claimed its first ...

An FDA decision looms for Akebia Therapeutics and its proposed vadadustat treatment for anemia due to chronic kidney disease in adults on dialysis. The FDA, which turned away Akebia's initial ...